A New Injectable HIV Drug, Cabenuva Approved by FDA


A new HIV-1 injection that involves a two-month dosing interval, rilpivirine and cabotegravir (Cabenuva) has been issued approval by the FDA (US Food and Drug Administration). This medication is the first injectable complete HIV drug to be approved by the FDA. Cabenuva is used to treat adults living with HIV in adults. The initial approval … Read more